KR930702536A - 당단백질 IIb/IIIa에 대한 사람 모노클론 항체 - Google Patents

당단백질 IIb/IIIa에 대한 사람 모노클론 항체

Info

Publication number
KR930702536A
KR930702536A KR1019930701402A KR930701402A KR930702536A KR 930702536 A KR930702536 A KR 930702536A KR 1019930701402 A KR1019930701402 A KR 1019930701402A KR 930701402 A KR930701402 A KR 930701402A KR 930702536 A KR930702536 A KR 930702536A
Authority
KR
South Korea
Prior art keywords
human
iiia
platelet aggregation
glycoprotein iib
monoclonal antibodies
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1019930701402A
Other languages
English (en)
Korean (ko)
Inventor
요이찌 마추모토
야스오 이께다
마꼬또 한다
다까시 가와무라
도시노부 무라까미
사또시 사사끼
쯔요시 기무라
도모꼬 사가와
Original Assignee
히로시 이따가끼
데이진 가부시끼가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 히로시 이따가끼, 데이진 가부시끼가이샤 filed Critical 히로시 이따가끼
Publication of KR930702536A publication Critical patent/KR930702536A/ko
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2839—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily
    • C07K16/2848—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily against integrin beta3-subunit-containing molecules, e.g. CD41, CD51, CD61
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
KR1019930701402A 1991-09-17 1992-09-16 당단백질 IIb/IIIa에 대한 사람 모노클론 항체 Ceased KR930702536A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP26264091 1991-09-17
JP262640/1991 1991-09-17
PCT/JP1992/001181 WO1993006232A1 (fr) 1991-09-17 1992-09-16 ANTICORPS MONOCLONAL HUMAIN CONTRE LA GLYCOPROTEINE IIb/IIIa

Publications (1)

Publication Number Publication Date
KR930702536A true KR930702536A (ko) 1993-09-09

Family

ID=17378596

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019930701402A Ceased KR930702536A (ko) 1991-09-17 1992-09-16 당단백질 IIb/IIIa에 대한 사람 모노클론 항체

Country Status (6)

Country Link
EP (1) EP0557535B1 (cg-RX-API-DMAC10.html)
JP (1) JP2776634B2 (cg-RX-API-DMAC10.html)
KR (1) KR930702536A (cg-RX-API-DMAC10.html)
AU (1) AU659873B2 (cg-RX-API-DMAC10.html)
DE (1) DE69223606T2 (cg-RX-API-DMAC10.html)
WO (1) WO1993006232A1 (cg-RX-API-DMAC10.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6521594B1 (en) 1990-04-06 2003-02-18 La Jolla Cancer Research Foundation Method and composition for treating thrombosis
US5672585A (en) * 1990-04-06 1997-09-30 La Jolla Cancer Research Foundation Method and composition for treating thrombosis
US5780303A (en) * 1990-04-06 1998-07-14 La Jolla Cancer Research Foundation Method and composition for treating thrombosis
US6017877A (en) * 1990-04-06 2000-01-25 La Jolla Cancer Research Foundation Method and composition for treating thrombosis
WO1998055619A1 (de) * 1997-06-06 1998-12-10 Asat Ag Applied Science & Technology Anti-gpiib/iiia rekombinante antikörper
EP1300419B1 (en) * 2001-10-05 2007-06-13 Affimed Therapeutics AG Antibody of human origin for inhibiting thrombocyte aggregation
US8455627B2 (en) 2001-10-05 2013-06-04 Affimed Therapeutics, Ag Human antibody specific for activated state of platelet integrin receptor GPIIb/IIIa
CN1230447C (zh) 2002-07-17 2005-12-07 阮长耿 识别血小板膜糖蛋白的单克隆抗体及其在抗血栓治疗中的应用
US9035028B2 (en) * 2010-03-10 2015-05-19 Emory University Temperature sensitive conjugate compositions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0449879A1 (en) * 1988-11-25 1991-10-09 Centocor, Inc. Heterobifunctional antibodies having specificity for platelets and thrombolytic agents
EP0447489A1 (en) * 1988-12-01 1991-09-25 Centocor, Inc. Human platelet-specific antibodies
DE69020548T2 (de) * 1989-04-03 1996-03-07 Centocor Inc Blutplättchenspezifische immunokonjugate.

Also Published As

Publication number Publication date
EP0557535A1 (en) 1993-09-01
EP0557535B1 (en) 1997-12-17
WO1993006232A1 (fr) 1993-04-01
DE69223606T2 (de) 1998-07-16
AU659873B2 (en) 1995-06-01
AU2583492A (en) 1993-04-27
DE69223606D1 (de) 1998-01-29
EP0557535A4 (cg-RX-API-DMAC10.html) 1994-02-16
JP2776634B2 (ja) 1998-07-16

Similar Documents

Publication Publication Date Title
Woods et al. Autoantibodies against the platelet glycoprotein IIb/IIIa complex in patients with chronic ITP
ATE331952T1 (de) Bestimmung von spezifischem immunglobulin unter verwendung multipler antigene
GR3036906T3 (en) Monoclonal antibody which specifically binds to tumor vascular endothelium and uses thereof.
DE69233724D1 (de) Bindungsdomänen des Serrate-Proteins
EP0176355A3 (en) Antigen-independent immunoassay system
KR890701771A (ko) Hiv 항원에 특이적인 단일 클론 항체
DE69718261D1 (de) Für staphylococcus aureus spezifischer antikörper und seine verwendung
DE69637890D1 (de) Monoklonaler antikörper für die inhibierung von hiv-1-hüllgykoprotein-vermittelte membranfusion
PT649537E (pt) Imunoanalises para anticorpos anti-vhc utilizando antigenios com epitopos conformacionais
Saluk et al. The unique molecular weight of the heavy chain from human IgG3
DK0853633T3 (da) Humant monoklonalt antistof imod hepatitis B virus overfladeantigen (HBVsAg)
KR930702536A (ko) 당단백질 IIb/IIIa에 대한 사람 모노클론 항체
ATE177758T1 (de) Synthetische peptide, antikörper dagegen und ihre verwendung
ATE155490T1 (de) Monoklonale antikörper gegen neue faktor-viii gerinnungspolypeptide
ATE120233T1 (de) Monoklonale antikörper, b-spezifisch für apolipoprotein, die von zwei hybridomen erzeugt werden.
DE59508474D1 (de) RHEUMAFAKTOR-ENTSTÖRUNG MIT ANTI-Fd-ANTIKÖRPERN
DK1144006T3 (da) Synergistisk inhibering af HIV-1-fusion og -binding, præparater og antistoffer dertil
DE3581288D1 (de) Antileishmania monoklonale antikoerper, diese antikoerper ausscheidende hybridomas, von diesen antikoerpern erkannte leishmaniaantigene, verfahren zur herstellung und verwendung von diesen monoklonalen antikoerpern und antigenen.
DE3580382D1 (de) Monoklonale antikoerper gegen alpha-2 interferon und hybridomas, die solche antikoerper produzieren.
CA2126182A1 (en) Humanized antibodies reactive with gpiib/iiia
DE69224134D1 (de) Monoklonale Antikörper gegen Hepatitis-C-Virus
DE3851492D1 (de) Ein gattungsspezifisches Listeria-Antigen, identifiziert durch monoklonale Antikörper.
KR910018041A (ko) Pp4에 대한 모노클로날 항체, 이의 제조방법 및 용도
Cosgrove et al. HLA (class I) antigens on platelets are involved in platelet function
DE68917797D1 (de) Gegen menschliches Fibrinopepid A spezifische monoklonale Antikörper.

Legal Events

Date Code Title Description
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 19930510

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 19970813

Comment text: Request for Examination of Application

Patent event code: PA02011R01I

Patent event date: 19930510

Comment text: Patent Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 19990515

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 19990904

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 19990515

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I